Skip to content
Home/Companies/MedTech/Stago
Stago

Stago

MedTech·France·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Stago?

Stago is currently owned by ARCHIMED through MED I (2014 vintage), since 2026.

Hand-verified · updated 2026-05-07

ARCHIMED
Investor
ARCHIMED
MED I · 2014 · Buyout

Key facts

SectorMedTech
StatusActive
Websitewww.stago.com

More from MED I

Other portfolio companies in the same fund.

Fytexia
Exited 2023
HealthTechFrance· 2016
to
Micromed
Micromed
Exited 2023
MedTechFrance· 2016
to
Natural Origins
Natural Origins
Exited 2017
HealthTechFrance· 2016
to
Polyplus
Polyplus
Exited 2023
BiotechFrance· 2016
to
Deallus
Exited 2024
PharmaUK· 2015
to
Primo Group
Primo Group
Exited 2024
HealthTechItaly· 2015
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Stago

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Stago.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue